Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration?

被引：6
|
作者：
Huqi, Alda [1 ,2 ]
Zoccali, Carmine [3 ,4 ]
Giugliano, Robert P. [5 ]
De Caterina, Raffaele [1 ,2 ,6 ]
机构：
[1] Univ Pisa, Chair Cardiol, Via Paradisa 2, I-56124 Pisa, Italy
[2] Pisa Univ Hosp, Cardiol Div, Via Paradisa 2, I-56124 Pisa, Italy
[3] Renal Res Inst, New York, NY USA
[4] Osped Riuniti Reggio Calabria, Nefrol CNR, Assoc Ipertens Nefrol Trapianto Renale IPNET, Reggio Di Calabria, Italy
[5] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
[6] Fdn VillaSerena Ric, Pescara, Italy
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 04期
关键词：
LINE RENAL-FUNCTION; WARFARIN; EDOXABAN; DABIGATRAN; STROKE; TRIAL;
D O I：
10.1093/eurheartj/ehac450
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：322 / 325
页数：4
相关论文
共 50 条
  • [1] Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
    Plitt, Anna
    Ruff, Christian T.
    Giugliano, Robert P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (05) : 1019 - +
  • [2] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
    Cha, Myung-Jin
    Choi, Eue-Keun
    Han, Kyung-Do
    Lee, So-Ryoung
    Lim, Woo-Hyun
    Oh, Seil
    Lip, Gregory Y. H.
    STROKE, 2017, 48 (11) : 3040 - +
  • [3] Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients
    Zhu, Wengen
    Ye, Zi
    Chen, Shilan
    Wu, Dexi
    He, Jiangui
    Dong, Yugang
    Lip, Gregory Y. H.
    Liu, Chen
    STROKE, 2021, 52 (04) : 1225 - 1233
  • [4] Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
    Undas, Anetta
    Drabik, Leszek
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 23 (01): : 10 - 18
  • [5] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia
    Janion-Sadowska, Agnieszka
    Papuga-Szela, Elbieta
    Lukaszuk, Robert
    Chrapek, Magdalena
    Undas, Anetta
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 72 (03) : 153 - 160
  • [6] Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Middeldorp, Melissa E.
    Gupta, Aashray
    Elliott, Adrian
    Kadhim, Kadhim
    Thiyagarajah, Anand
    Gallagher, Celine
    Hendriks, Jeroen
    Linz, Dominik
    Emami, Mehrdad
    Mahajan, Rajiv
    Lau, Dennis
    Sanders, Prashanthan
    HEART, 2021, 107 (12) : 971 - 976
  • [7] The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly
    Patti, Giuseppe
    Cavallari, Ilaria
    Hanon, Olivier
    De Caterina, Raffaele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 : 118 - 124
  • [8] Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation
    Fanaroff, Alexander C.
    Ohman, E. Magnus
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 61 - 75
  • [9] Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation
    Basaran, Ozcan
    Dogan, Volkan
    Sahin, Cem
    Biteker, Murat
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 : 357 - 357
  • [10] Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation
    Senoo, Keitaro
    Lip, Gregory Y. H.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (02): : 146 - 153
12345